A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.
Clinical trial NCT05203601 · COMPLETED
Trial details
- NCT number
- NCT05203601
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-26
- Primary completion
- 2022-12-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.